Top Markets
#1 Black Phoenix Black Phoenix +17,849.79%
#2 Cash Dog in Hood Cash Dog in Hood +6,497.44%
#3 AgentFun.AI AgentFun.AI +54.83%
#4 up up +51.83%
#5 Arrow Arrow +50.00%
#6 Quai Network Quai Network +39.61%
#7 Octra Octra +37.18%
#8 Derive Derive +34.26%
#9 B3 (Base) B3 (Base) +29.84%
#10 Block Street Block Street +28.94%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Kedudukan dalam Saham #15063
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Harga Saham
$4.66
Modal Pasaran
$43.92M
Perubahan (1 hari)
-0.63%
Perubahan (1 tahun)
338.04%
Negara
FR
Perdagangan Theranexus Société Anonyme (ALTHX)

Kategori

Healthcare
Pendapatan untuk Theranexus Société Anonyme (ALTHX)
Pendapatan pada Dec 2025 TTM: $-4.69M
Menurut laporan kewangan terkini Theranexus Société Anonyme, pendapatan semasa syarikat ialah $-4.69M. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $-8.43M, penurunan berbanding pendapatan pada tahun 2022 yang berjumlah $-7.71M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Theranexus Société Anonyme dari 2015 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $-4.69M 78.02%
2024 $-2.64M -68.75%
2023 $-8.43M 9.42%
2022 $-7.71M -31.59%
2021 $-11.27M 59.76%
2020 $-7.05M -17.48%
2019 $-8.55M 5.93%
2018 $-8.07M 136.36%
2017 $-3.41M 49.60%
2016 $-2.28M 87.07%
2015 $-1.22M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
$24.72B -526,837.33%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.17B -110,182.16%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.16B -109,994.63%
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -45,654.73%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.66B -35,379.08%
NL